Literature DB >> 32135144

Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.

Samuel C R Sherratt1, Rebecca A Juliano2, R Preston Mason3.   

Abstract

BACKGROUND: Oxidation of small dense low-density lipoprotein (sdLDL) and membranes is causally related to atherosclerosis. The omega-3 fatty acid (FA) eicosapentaenoic acid (EPA, 20:5, ω-3) significantly reduced oxidized LDL in patients with hypertriglyceridemia by unknown mechanisms. We compared EPA effects to related FAs of varying chain length and unsaturation on oxidation of sdLDL and model membranes, and on cholesterol crystal domains. We compared EPA to the FAs: stearic (SA, 18:0), oleic (OA, 18:1, ω-9), linoleic (LA, 18:2, ω-6), alpha-linolenic (ALA, 18:3, ω-3), eicosanoic (EA, 20:0), eicosatrienoic (ETE, 20:3, ω-3), arachidonic (AA, 20:4, ω-6), docosapentaenoic (DPA, 22:5, ω-3), and docosahexaenoic (DHA, 22:6, ω-3).
METHODS: Human sdLDL or model membranes of cholesterol and 1,2-Dilinoleoyl-sn-glycero-3-phosphocholine [18:2(cis)PC or DLPC] were preincubated with FAs followed by copper-induced oxidation. Malondialdehyde (MDA) or lipid hydroperoxides (LOOH) levels measured oxidation; small-angle X-ray diffraction assessed cholesterol domain formation.
RESULTS: After 40 min, EPA reduced MDA levels 70% compared to vehicle (p < 0.001). Lesser inhibition was observed with DHA, DPA, ETE, and ALA (33%, 34%, 32%, and 16%, respectively; all p < 0.001 versus vehicle). Similar relative FA effects were observed in model membranes where EPA more substantially inhibited cholesterol crystal domain formation.
CONCLUSION: We observed relationships between hydrocarbon length and unsaturation with antioxidant activity and membrane cholesterol domain formation. EPA had the most favorable molecular structure, likely contributing to membrane stability, improved lipoprotein clearance, and reduced inflammation. GENERAL SIGNIFICANCE: Insight is provided into FA hydrocarbon length and unsaturation relationships with antioxidant activity in lipoproteins and membranes, and cholesterol crystal domains formation.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eicosapentaenoic acid; Lipid oxidation; Lipoproteins; Omega-3 fatty acids

Year:  2020        PMID: 32135144     DOI: 10.1016/j.bbamem.2020.183254

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  11 in total

Review 1.  Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.

Authors:  Renato Quispe; Abdulhamied Alfaddagh; Brigitte Kazzi; Fawzi Zghyer; Francoise A Marvel; Roger S Blumenthal; Garima Sharma; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2022-04-30       Impact factor: 5.967

2.  Antarctic Krill Oil Attenuates Oxidative Stress via the KEAP1-NRF2 Signaling in Patients with Coronary Heart Disease.

Authors:  Chengfei Wen; Mi Jiang; Weixin Huang; Shumei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-07       Impact factor: 2.629

3.  Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites.

Authors:  Timothy D O'Connell; Richard Preston Mason; Matthew J Budoff; Ann Marie Navar; Gregory C Shearer
Journal:  Eur Heart J Suppl       Date:  2020-10-06       Impact factor: 1.803

Review 4.  Omega-3 Polyunsaturated Fatty Acids-Vascular and Cardiac Effects on the Cellular and Molecular Level (Narrative Review).

Authors:  Ines Drenjančević; Jan Pitha
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

Review 5.  Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.

Authors:  Xiao Jin; Shengjie Yang; Jing Lu; Min Wu
Journal:  Front Cardiovasc Med       Date:  2022-02-10

Review 6.  Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL.

Authors:  Jelena Vekic; Aleksandra Zeljkovic; Aleksandra Stefanovic; Natasa Bogavac-Stanojevic; Ioannis Ilias; José Silva-Nunes; Anca Pantea Stoian; Andrej Janez; Manfredi Rizzo
Journal:  Pharmaceutics       Date:  2022-04-09       Impact factor: 6.525

7.  Milk Fatty Acids Composition Changes According to β-Hydroxybutyrate Concentrations in Ewes during Early Lactation.

Authors:  Enrico Fiore; Anastasia Lisuzzo; Rossella Tessari; Nicoletta Spissu; Livia Moscati; Massimo Morgante; Matteo Gianesella; Tamara Badon; Elisa Mazzotta; Michele Berlanda; Barbara Contiero; Filippo Fiore
Journal:  Animals (Basel)       Date:  2021-05-12       Impact factor: 2.752

Review 8.  The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction.

Authors:  Xiaowen Wang; Subodh Verma; R Preston Mason; Deepak L Bhatt
Journal:  Curr Diab Rep       Date:  2020-10-23       Impact factor: 4.810

9.  Atherosclerosis Development and Aortic Contractility in Hypercholesterolemic Rabbits Supplemented with Two Different Flaxseed Varieties.

Authors:  Jolanta Bujok; Dorota Miśta; Edyta Wincewicz; Bożena Króliczewska; Stanisław Dzimira; Magdalena Żuk
Journal:  Foods       Date:  2021-03-04

Review 10.  Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids.

Authors:  Manuel Torres; Sebastià Parets; Javier Fernández-Díaz; Roberto Beteta-Göbel; Raquel Rodríguez-Lorca; Ramón Román; Victoria Lladó; Catalina A Rosselló; Paula Fernández-García; Pablo V Escribá
Journal:  Membranes (Basel)       Date:  2021-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.